208 related articles for article (PubMed ID: 38730725)
1. MIF and CD74 as Emerging Biomarkers for Immune Checkpoint Blockade Therapy.
Fey RM; Nichols RA; Tran TT; Vandenbark AA; Kulkarni RP
Cancers (Basel); 2024 May; 16(9):. PubMed ID: 38730725
[TBL] [Abstract][Full Text] [Related]
2. MIF inhibition as a strategy for overcoming resistance to immune checkpoint blockade therapy in melanoma.
de Azevedo RA; Shoshan E; Whang S; Markel G; Jaiswal AR; Liu A; Curran MA; Travassos LR; Bar-Eli M
Oncoimmunology; 2020 Dec; 9(1):1846915. PubMed ID: 33344042
[TBL] [Abstract][Full Text] [Related]
3. Immune checkpoint blockade toxicity among patients with cancer presenting to the emergency department.
Peyrony O; Tieghem Y; Franchitti J; Ellouze S; Morra I; Madelaine-Chambrin I; Flicoteaux R; Baroudjian B; Azoulay E; Chevret S; Fontaine JP
Emerg Med J; 2019 May; 36(5):306-309. PubMed ID: 30910911
[TBL] [Abstract][Full Text] [Related]
4. The current landscape of predictive and prognostic biomarkers for immune checkpoint blockade in ovarian cancer.
Xu Y; Zuo F; Wang H; Jing J; He X
Front Immunol; 2022; 13():1045957. PubMed ID: 36389711
[TBL] [Abstract][Full Text] [Related]
5. Blockade of MIF-CD74 Signalling on Macrophages and Dendritic Cells Restores the Antitumour Immune Response Against Metastatic Melanoma.
Figueiredo CR; Azevedo RA; Mousdell S; Resende-Lara PT; Ireland L; Santos A; Girola N; Cunha RLOR; Schmid MC; Polonelli L; Travassos LR; Mielgo A
Front Immunol; 2018; 9():1132. PubMed ID: 29875777
[TBL] [Abstract][Full Text] [Related]
6. Macrophage migration inhibitory factor-CD74 interaction regulates the expression of programmed cell death ligand 1 in melanoma cells.
Imaoka M; Tanese K; Masugi Y; Hayashi M; Sakamoto M
Cancer Sci; 2019 Jul; 110(7):2273-2283. PubMed ID: 31069878
[TBL] [Abstract][Full Text] [Related]
7. Upregulation of CD74 and its potential association with disease severity in subjects with ischemic stroke.
Yang L; Kong Y; Ren H; Li M; Wei CJ; Shi E; Jin WN; Hao J; Vandenbark AA; Offner H
Neurochem Int; 2017 Jul; 107():148-155. PubMed ID: 27884769
[TBL] [Abstract][Full Text] [Related]
8. A computational assessment of the predicted structures of Human Macrophage Migration Inhibitory Factor 1 orthologs in parasites and its affinity to human CD74 receptor.
Machicado C; Marcos LA
J Mol Recognit; 2017 Oct; 30(10):. PubMed ID: 28513076
[TBL] [Abstract][Full Text] [Related]
9. Cell Surface CD74-MIF Interactions Drive Melanoma Survival in Response to Interferon-γ.
Tanese K; Hashimoto Y; Berkova Z; Wang Y; Samaniego F; Lee JE; Ekmekcioglu S; Grimm EA
J Invest Dermatol; 2015 Nov; 135(11):2775-2784. PubMed ID: 26039541
[TBL] [Abstract][Full Text] [Related]
10. Role of MIF/CD74 signaling pathway in the development of pleural mesothelioma.
D'Amato-Brito C; Cipriano D; Colin DJ; Germain S; Seimbille Y; Robert JH; Triponez F; Serre-Beinier V
Oncotarget; 2016 Mar; 7(10):11512-25. PubMed ID: 26883190
[TBL] [Abstract][Full Text] [Related]
11. Macrophage migration inhibitory factor and CD74 regulate macrophage chemotactic responses via MAPK and Rho GTPase.
Fan H; Hall P; Santos LL; Gregory JL; Fingerle-Rowson G; Bucala R; Morand EF; Hickey MJ
J Immunol; 2011 Apr; 186(8):4915-24. PubMed ID: 21411731
[TBL] [Abstract][Full Text] [Related]
12. Serum Levels of Migration Inhibitory Factor (MIF) and
Martinez-Guzman MA; Alvarado-Navarro A; Delgado-Rizo V; Garcia-Orozco A; Mayorga-Rodríguez JA; Pereira-Suarez AL; Fafutis-Morris M
Front Immunol; 2018; 9():246. PubMed ID: 29487601
[TBL] [Abstract][Full Text] [Related]
13. Association of Immune-Related Adverse Events, Hospitalization, and Therapy Resumption With Survival Among Patients With Metastatic Melanoma Receiving Single-Agent or Combination Immunotherapy.
Watson AS; Goutam S; Stukalin I; Ewanchuk BW; Sander M; Meyers DE; Pabani A; Cheung WY; Heng DYC; Cheng T; Monzon JG; Navani V
JAMA Netw Open; 2022 Dec; 5(12):e2245596. PubMed ID: 36480204
[TBL] [Abstract][Full Text] [Related]
14. Expression of macrophage migration inhibitory factor and CD74 in cervical squamous cell carcinoma.
Cheng RJ; Deng WG; Niu CB; Li YY; Fu Y
Int J Gynecol Cancer; 2011 Aug; 21(6):1004-12. PubMed ID: 21792010
[TBL] [Abstract][Full Text] [Related]
15. Macrophage migration inhibitory factor promotes the migration of dendritic cells through CD74 and the activation of the Src/PI3K/myosin II pathway.
Ives A; Le Roy D; Théroude C; Bernhagen J; Roger T; Calandra T
FASEB J; 2021 May; 35(5):e21418. PubMed ID: 33774873
[TBL] [Abstract][Full Text] [Related]
16. LPS-mediated cell surface expression of CD74 promotes the proliferation of B cells in response to MIF.
Klasen C; Ziehm T; Huber M; Asare Y; Kapurniotu A; Shachar I; Bernhagen J; El Bounkari O
Cell Signal; 2018 Jun; 46():32-42. PubMed ID: 29476963
[TBL] [Abstract][Full Text] [Related]
17. Inhibition of macrophage migration inhibitory factor or its receptor (CD74) attenuates growth and invasion of DU-145 prostate cancer cells.
Meyer-Siegler KL; Iczkowski KA; Leng L; Bucala R; Vera PL
J Immunol; 2006 Dec; 177(12):8730-9. PubMed ID: 17142775
[TBL] [Abstract][Full Text] [Related]
18. Macrophage migration inhibitory factor exerts pro-proliferative and anti-apoptotic effects via CD74 in murine hepatocellular carcinoma.
Wirtz TH; Saal A; Bergmann I; Fischer P; Heinrichs D; Brandt EF; Koenen MT; Djudjaj S; Schneider KM; Boor P; Bucala R; Weiskirchen R; Bernhagen J; Trautwein C; Berres ML
Br J Pharmacol; 2021 Nov; 178(22):4452-4467. PubMed ID: 34250589
[TBL] [Abstract][Full Text] [Related]
19. Interaction Between Macrophage Migration Inhibitory Factor and CD74 in Human Immunodeficiency Virus Type I Infected Primary Monocyte-Derived Macrophages Triggers the Production of Proinflammatory Mediators and Enhances Infection of Unactivated CD4
Trifone C; Salido J; Ruiz MJ; Leng L; Quiroga MF; Salomón H; Bucala R; Ghiglione Y; Turk G
Front Immunol; 2018; 9():1494. PubMed ID: 29997630
[TBL] [Abstract][Full Text] [Related]
20. Expression of CD74, the receptor for macrophage migration inhibitory factor, in non-small cell lung cancer.
McClelland M; Zhao L; Carskadon S; Arenberg D
Am J Pathol; 2009 Feb; 174(2):638-46. PubMed ID: 19131591
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
